Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Krystal Biotech, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, in San Francisco, with CEO Krish S. Krishnan scheduled to present at 10:30 am ET [1] - A webcast of the presentation will be available on the Company's website starting at the same time [2] Company Overview - Krystal Biotech, Inc. is a fully integrated, commercial-stage global biotechnology company focused on genetic medicines for diseases with high unmet medical needs [3] - The Company's first commercial product, VYJUVEK, is the first-ever redosable gene therapy and the first genetic medicine approved in the US, Europe, and Japan for treating dystrophic epidermolysis bullosa [3] - The Company is advancing a robust pipeline of investigational genetic medicines across various fields, including respiratory, oncology, dermatology, ophthalmology, and aesthetics [3]